HeartBeam enters into $13M at-the-market equity sales agreement with A.G.P.

HeartBeam, Inc.

Up to $13M of common stock may be sold through A.G.P. in at-the-market offerings under existing S-3.
A.G.P. receives a 3.0% commission on gross proceeds from each sale of shares.
Net proceeds intended for working capital and general corporate purposes.
Sales agreement dated February 1, 2023; company may issue shares from time to time at its option.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HeartBeam, Inc. entered into Sales Agreement with A.G.P./Alliance Global Partners valued at approximately $13,000,000 (effective 2023-02-01).

Action: entry
Agreement: atm program
Counterparty: A.G.P./Alliance Global Partners
Value: approximately $13,000,000
Effective: 2023-02-01

Exact text from the filing

On February 1, 2023, HeartBeam, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners, as sales agent (“A.G.P.”), pursuant to which the Company may offer and sell (the “Offering”), from time to time, at its option, through or to A.G.P., up to an aggregate of approximately $13,000,000 of shares of the Company’s common stock, $0.0001 par value per share (the “Shares”).

View on SEC.gov

Browse all material agreements →

HeartBeam, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-006955

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.